Removal of Novarsc by Domestic Hospital

An industry source reported last week that the Severance Hospital Group has removed Pfizer Korea's Novarsc, an anti-hypertension drug, from its available group of prescription-based treatments.

According to the source, the Severance Hospital Group excluded Pfizer Korea's Novarsc in the annual contract negotiations that were held during last December. Instead, the Hospital is reported to fin...